416 related articles for article (PubMed ID: 26255114)
1. Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances.
Nash KM; Ahmed S
Nanomedicine; 2015 Nov; 11(8):2033-40. PubMed ID: 26255114
[TBL] [Abstract][Full Text] [Related]
2. The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities.
Eftekhari A; Dizaj SM; Chodari L; Sunar S; Hasanzadeh A; Ahmadian E; Hasanzadeh M
Biomed Pharmacother; 2018 Jul; 103():1018-1027. PubMed ID: 29710659
[TBL] [Abstract][Full Text] [Related]
3. Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease.
Hasan I; Guo B; Zhang J; Chang C
Antioxid Redox Signal; 2024 May; 40(13-15):863-888. PubMed ID: 36070437
[No Abstract] [Full Text] [Related]
4. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
[TBL] [Abstract][Full Text] [Related]
5. Nitroxide radicals and nanoparticles: a partnership for nanomedicine radical delivery.
Nagasaki Y
Ther Deliv; 2012 Feb; 3(2):165-79. PubMed ID: 22834195
[TBL] [Abstract][Full Text] [Related]
6. Bilirubin Nanomedicines for the Treatment of Reactive Oxygen Species (ROS)-Mediated Diseases.
Chen Z; Vong CT; Gao C; Chen S; Wu X; Wang S; Wang Y
Mol Pharm; 2020 Jul; 17(7):2260-2274. PubMed ID: 32433886
[TBL] [Abstract][Full Text] [Related]
7. Nanocarrier-mediated antioxidant delivery for liver diseases.
Li S; Li H; Xu X; Saw PE; Zhang L
Theranostics; 2020; 10(3):1262-1280. PubMed ID: 31938064
[TBL] [Abstract][Full Text] [Related]
8. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
[TBL] [Abstract][Full Text] [Related]
9. Reactive Oxygen Species (ROS)-Based Nanomedicine.
Yang B; Chen Y; Shi J
Chem Rev; 2019 Apr; 119(8):4881-4985. PubMed ID: 30973011
[TBL] [Abstract][Full Text] [Related]
10. The redox-active nanomaterial toolbox for cancer therapy.
Ibañez IL; Notcovich C; Catalano PN; Bellino MG; Durán H
Cancer Lett; 2015 Apr; 359(1):9-19. PubMed ID: 25597786
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic strategies to target oxidative stress in heart failure.
Ahmed Z; Tang WH
Curr Heart Fail Rep; 2012 Mar; 9(1):14-22. PubMed ID: 22213193
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria-targeted antioxidant peptides.
Rocha M; Hernandez-Mijares A; Garcia-Malpartida K; Bañuls C; Bellod L; Victor VM
Curr Pharm Des; 2010; 16(28):3124-31. PubMed ID: 20687871
[TBL] [Abstract][Full Text] [Related]
13. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury.
Yu H; Jin F; Liu D; Shu G; Wang X; Qi J; Sun M; Yang P; Jiang S; Ying X; Du Y
Theranostics; 2020; 10(5):2342-2357. PubMed ID: 32104507
[TBL] [Abstract][Full Text] [Related]
14. Self-Assembling Antioxidants for Ischemia-Reperfusion Injuries.
Yoshitomi T; Nagasaki Y
Antioxid Redox Signal; 2022 Jan; 36(1-3):70-80. PubMed ID: 34074133
[No Abstract] [Full Text] [Related]
15. Free radicals and antioxidants in normal physiological functions and human disease.
Valko M; Leibfritz D; Moncol J; Cronin MT; Mazur M; Telser J
Int J Biochem Cell Biol; 2007; 39(1):44-84. PubMed ID: 16978905
[TBL] [Abstract][Full Text] [Related]
16. Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities.
Jain AK; Mehra NK; Swarnakar NK
Curr Pharm Des; 2015; 21(30):4441-55. PubMed ID: 26234792
[TBL] [Abstract][Full Text] [Related]
17. Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.
Kim KS; Song CG; Kang PM
Antioxid Redox Signal; 2019 Feb; 30(5):733-746. PubMed ID: 29228781
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic functions of antioxidant nanoparticles for longevity and medicine.
Narayanan KB; Park HH
Adv Colloid Interface Sci; 2013 Dec; 201-202():30-42. PubMed ID: 24206941
[TBL] [Abstract][Full Text] [Related]
19. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
20. Relevance of nanotechnology in modulating oxidative stress: an overview.
Bharali DJ; Mousa SA
Methods Mol Biol; 2013; 1028():289-92. PubMed ID: 23740128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
